Novel Therapeutics Preparedness Act

Summary#

This bill creates an Office of Novel Therapeutics inside the Veterans Health Administration (VHA). The Office will be led by a Director who reports to the Under Secretary for Health. The Office will be the central authority for evaluating, researching, and planning how the VHA might implement emerging therapeutic interventions that are under Food and Drug Administration review, including certain psychedelic-assisted therapies mentioned in the bill.

The Office must develop national policy, clinical standards, and a national clinical model for intensive therapeutic interventions. Duties include guidance on patient eligibility, implementation-readiness plans (facility needs, team composition, protected clinical time, safety monitoring, and integration with suicide prevention, PTSD, and substance use programs), workforce-readiness assessments, national training and credentialing standards, and distinguishing research from clinical care.

The bill requires a Clinical Implementation Program to test care delivery models and gather real-world evidence on effectiveness, feasibility, safety, and scalability. The Program may prioritize conditions such as post-traumatic stress disorder, treatment-resistant depression, substance use disorders, suicidality, traumatic brain injury, repetitive low-level blast exposure, chronic pain, and co-occurring conditions.

The Secretary may designate Centers of Excellence for novel therapeutics that lead research, training, and technical assistance. The bill also creates a Veteran Advisory Committee to advise the Office, requires interagency coordination (including HHS, FDA, CMS, DoD, and DEA), mandates an annual report to Congress on research, outcomes, safety events, and implementation barriers, and requires the Secretary to submit a national preparedness and implementation strategy to Congress within 180 days covering workforce capacity, facility modifications, timelines, and barriers.

What it means for you#

• For veterans: The bill directs the VHA to plan and test new ways to offer emerging mental health treatments and to include veteran input through an advisory committee. It may lead to pilot programs at designated centers and guidance on who may be eligible for those treatments.
• For VHA clinicians and staff: The bill calls for national training, credentialing, and workforce-readiness assessments. It also requires protected clinical time and standards for interdisciplinary teams when intensive therapies are provided.
• For local facilities and partners: The VHA must identify at least one medical center per Veterans Integrated Service Network (VISN) to build readiness, and Centers of Excellence will provide technical assistance and training. The bill also asks the VHA to coordinate with community organizations for aftercare.

Expenses#

No publicly available information on costs, appropriations, or funding levels is included in the bill text or the provided metadata.

Proponents' View#

The bill's findings say emerging therapeutic interventions may change treatment for PTSD, depression, and other veteran mental health conditions. Proponents in the bill argue the administration of these therapies often requires intensive clinical engagement and different care models, and that the VHA is well placed to deliver integrated care. The bill frames a dedicated Office as a way to avoid delays, safety risks, and inconsistent access and to support responsible, evidence-based evaluation and implementation.

Opponents' View#

No publicly available information on opposition positions or critiques is included in the bill text or the provided metadata.